当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析

悦康药业

(688658)

  

流通市值:113.40亿  总市值:113.40亿
流通股本:4.50亿   总股本:4.50亿

悦康药业(688658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.02亿元,每股收益-0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益348277.65万元,未分配利润29072.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产528933.08万元,负债180655.43万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,167,382,036.87577,383,322.423,780,875,989.992,991,795,632.65
营业总成本1,269,538,108.89629,257,575.773,563,397,7872,730,072,277.72
其他经营收益
营业利润-106,687,438.02-58,452,400.07159,062,907.37254,972,423.52
利润总额-107,254,520.15-59,029,628.62152,357,607.35248,270,396.38
净利润-102,180,151.14-49,498,244.14121,246,883.89208,200,539.69
每股收益
其他综合收益----
综合收益总额-102,180,151.14-49,498,244.14121,246,883.89208,200,539.69
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,640,753,385.193,037,807,721.743,157,931,976.133,426,215,958.44
非流动资产:
非流动资产合计2,648,577,451.182,573,524,520.42,580,180,448.592,577,494,244.25
资产总计5,289,330,836.375,611,332,242.145,738,112,424.726,003,710,202.69
流动负债:
流动负债合计1,331,188,204.331,401,752,107.41,505,511,582.121,762,693,023.21
非流动负债:
非流动负债合计475,366,107.55674,121,703.25647,644,166.97569,106,848.05
负债合计1,806,554,311.882,075,873,810.652,153,155,749.092,331,799,871.26
所有者权益(或股东权益):
归属于母公司股东权益合计3,478,800,821.563,528,358,831.943,577,629,966.773,663,638,001.19
股东权益合计3,482,776,524.493,535,458,431.493,584,956,675.633,671,910,331.43
负债和股东权益合计5,289,330,836.375,611,332,242.145,738,112,424.726,003,710,202.69
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,474,171,331.07701,625,737.654,362,044,451.43,326,912,990.09
经营活动现金流出小计1,481,393,781.07620,584,104.463,923,803,798.912,896,427,143.69
经营活动产生的现金流量净额-7,222,45081,041,633.19438,240,652.49430,485,846.4
投资活动产生的现金流量:
投资活动现金流入小计191,731,484.6965,938,894.02849,037.861,315,297.18
投资活动现金流出小计444,903,020.9367,707,427.51546,607,767.73321,426,486.01
投资活动产生的现金流量净额-253,171,536.24-1,768,533.49-545,758,729.87-320,111,188.83
筹资活动产生的现金流量:
筹资活动现金流入小计128,588,063.975,588,063.9649,010,636.01523,673,304.58
筹资活动现金流出小计124,583,987.5111,857,511.31677,470,460.5526,928,672.15
筹资活动产生的现金流量净额4,004,076.3963,730,552.59-28,459,824.49-3,255,367.57
汇率变动对现金及现金等价物的影响107,617.2344,062.23263,852.38502,565.99
现金及现金等价物净增加额-256,282,292.62143,047,714.52-135,714,049.49107,621,855.99
期末现金及现金等价物余额981,536,848.181,380,859,375.771,237,819,140.81,481,155,046.28
补充资料:
现金及现金等价物的净增加额-256,282,292.62--135,714,049.49-
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券余汝意0.110.461.252025-08-30
中信证券陈竹,韩世通0.140.400.872025-07-16
TOP↑